Australia Stock Exchange release from PATRYS : Patrys completes PAT-DX1 and PAT-DX3 pharmacokinetic studies
22/04/2021 24:13
Australia Stock Exchange release from PATRYS PAB.AX : Patrys completes PAT-DX1 and PAT-DX3 pharmacokinetic studies
- AU$18.00m
- AU$14.64m
- AU$0.01m